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Abstract: Roles of Clock genes and the bone morphogenetic protein (BMP) system in the regulation of
gonadotropin secretion by gonadotropin-releasing hormone (GnRH) were investigated using mouse
gonadotropin LβT2 cells. It was found that luteinizing hormone (LH)β mRNA expression level in
LβT2 cells changed gradually over time, with LHβ expression being suppressed in the early phase
up to 12 h and then elevated in the late phase 24 h after GnRH stimulation. In addition, the mRNA
expression levels of Clock genes, including Bmal1, Clock, Per2, and Cry1, also showed temporal
changes mimicking the pattern of LHβ expression in the presence and absence of GnRH. Notably,
the expression levels of Bmal1 and Clock showed strong positive correlations with LHβ mRNA
expression levels. Moreover, a functional link of the ERK signaling of mitogen-activated protein
kinases (MAPKs) in the suppression of LHβ mRNA expression, as well as Bmal1 and Clock mRNA
expression by GnRH at the early phase, was revealed. Inhibition of Bmal1 and Clock expression
using siRNA was involved in the reduction in LHβ mRNA levels in the late phase 24 h after GnRH
stimulation. Furthermore, in the presence of BMP-6 and -7, late-phase Bmal1 and LHβ mRNA
expression after GnRH stimulation was significantly attenuated. Collectively, the results indicated
that LH expression in gonadotrope cells exhibits Bmal1/Clock-dependent fluctuations under the
influence of GnRH and that the fluctuations are regulated by ERK and BMPs in the early and late
stages, respectively, in a phase-dependent manner after GnRH stimulation.
Keywords: bone morphogenetic protein (BMP); Clock; gonadotropins; luteinizing hormone; mitogen-
activated protein kinase (MAPK)
1. Introduction
The circadian pacemaker has been shown to integrate physiological rhythms via
various hormonal and neurochemical transmitters by coordinating the oscillations of
peripheral clocks expressed in various tissues [1]. The pituitary tissue has also been
shown to incorporate the molecular Clock that plays autonomous roles in capturing and
sensitizing biological time [2,3]. Although anterior pituitary cells are mainly exposed
to and finely controlled by specific hypothalamic hormones, it has been presumed that
pituitary cells also possess their own Clock that is autonomously capable of oscillating at
the molecular level.
In the system of the circadian Clock, the four core proteins mutually interact at the
molecular level to promote transcription of the targets of circadian genes [4]. Among the
canonical Clock genes including Bmal1, Clock, Per1 to 3, and Cry1 and 2, the proteins of
Clock and Bmal1 can form a heterodimer that interacts with E-boxes and induces tran-
scription of Clock-related genes, including Per and Cry, and subsequently, the dimerized
proteins of Per and Cry suppress the transcriptional activity elicited by Clock and Bmal1 [4].
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In mammals, reproductive activity displays a cycling pattern driven by complicated
interactions of the circadian system, hypothalamic hormones, pituitary gonadotropins, and
gonadal steroids [5]. As for the human pituitary Clock, Wunderer et al. [6] demonstrated
the existence of Clock gene activity, although the functional activity of the Clock genes has
yet to be elucidated. Becquet et al. [7] further demonstrated that core genes of the pituitary
Clock can elicit a specific pattern of expressional changes in synchronized rat primary
cells, suggesting that a certain oscillator of the circadian rhythm exists in the pituitary.
These findings indicate that the endogenous Clock system seems to be functionally active
in pituitary cells. However, the physiological roles and their regulatory biology in the
pituitary have yet to be clarified.
Pulsatile secretion of hypothalamic gonadotropin-releasing hormone (GnRH) stim-
ulates synthesis and release of pituitary gonadotropins. The GnRH-receptor signaling
functionally involves heterotrimeric G proteins, phospholipase C (PLC), protein kinase C
(PKC), and calcium (Ca) influx operated in gonadotrope cells [8–10]. The elevated Ca++ and
PKC signals then promote activation of the mitogen-activated protein kinase (MAPK) fam-
ily members, including ERK1/2, P38, and SAPK/JNK pathways, which contribute to the
transcriptional control of gonadotropin subunits, leading to the induction of gonadotropin
synthesis and release by gonadotropes [9,10].
Moreover, there are various regulators for circadian rhythm, including cytokines and
growth factors expressed in the pituitary under the influence of GnRH. Among these, bone
morphogenetic proteins (BMPs) are growth factors that belong to the transforming growth
factor (TGF)-β superfamily. Not only the effects of BMPs for inducing bone formation but
also various biological activities of BMPs in endocrine tissues, including the pituitary and
gonads, have been uncovered [11–13]. BMPs have been shown to govern pituitary organo-
genesis as well as contributing to the phenotypic characteristics of differentiated pituitary
tissues [13–15]. For instance, BMP-4 was found to be overexpressed in lactotropinomas
derived from rodent and human prolactinomas [16,17]. BMP-4 was also found to be a
negative regulator of proopiomelanocortin expression and proliferation of corticotrope
cells [18–21]. We previously reported that pituitary BMPs are involved in the secretory
control of follicle-stimulating hormone (FSH) produced by gonadotropes [22–24]. In mouse
gonadotrope cells, BMP-6 enhanced FSH transcription in cooperation with GnRH, while
BMP-7 impaired GnRH-induced FSH transcription [25]. However, the regulatory mecha-
nism of luteinizing hormone (LH) secretion by GnRH and BMPs under the influence of
Clock gene oscillation has been unknown.
In the present study, we investigated the functional roles of Clock genes, including
Bmal, Clock, Per, and Cry, in the regulation of expression of LH induced by GnRH in
cooperation with the pituitary BMP system by using mouse gonadotrope cells.
2. Results
2.1. Serial Changes of LH and Clock Gene Expression Induced by GnRH
First, the changes in LHβ expression after GnRH (10 nM) stimulation were evaluated
by quantitative PCR in mouse gonadotrope LβT2 cells in serum-free conditions for 24 h by
sequentially collecting cellular RNA at the time points of 0, 1, 3, 6, 12, and 24 h. As shown
in Figure 1A, LHβ mRNA levels showed a gradual change over time in the presence or
absence of GnRH stimuli, with LHβ expression being suppressed in the early phase up
to 12 h and then elevated in the late phase 24 h after GnRH stimulation (Figure 1A, right
panel). Changes in the mRNA expression levels of Clock genes, including Bmal1, Clock,
Per2, and Cry1, were then examined, and it was found that the mRNA expression levels
showed LHβ-like temporal changes in the presence and absence of GnRH (Figure 1B).
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Figure 1. Serial changes in and interrelationships between LH and Clock gene expression induced by GnRH in mouse
gonadotrope cells. LβT2 cells (1 × 105 cells/mL) were cultured with GnRH (10 nM) in serum-free DMEM for 24 h. At
serial time points from 1 to 24 h, total RNAs were extracted, and the mRNA levels of (A) LHβ and (B) Bmal1, Clock, Per2,
and Cry1 genes were standardized by RPL19 levels and expressed as fold changes. Results are shown as means ± SEM
and were analyzed by the unpaired t-test: * p < 0.05 between the indicated groups. Ratios of LHβ mRNA levels in the
presence of GnRH (10 nM) to those in the absence of GnRH at each time point are shown in the right panel of (A). (C) Cells
(1 × 105 cells/mL) were treated with GnRH (10 nM) in serum-free conditions for 24 h. At serial time points from 1 to 24 h,
total RNAs were extracted, and linear regression analysis was performed to determine the interrelationships between
mRNA levels of LHβ and Clock genes. * p < 0.05 and ** p < 0.01 of the significant correlations.
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2.2. Interrelationships between LH and Clock Gene Expression
Next, the interrelationships between the expression of LHβ and the expression of
Clock genes in LβT2 cells were examined. The mRNA expression levels of LHβ and Clock
genes, including Bmal1, Clock, Per2, and Cry1, were determined in LβT2 cells serially
treated in the presence and absence of GnRH (10 nM) for 24 h. As shown in Figure 1C,
linear regression analysis among these factors showed that the most significant correlation
was between the mRNA expression levels of LHβ and Bmal1 (R2 = 0.86, ** p < 0.01: n = 98).
The second strongest correlation was that between mRNA expression levels of LHβ and
Clock (R2 = 0.71, ** p < 0.01: n = 98). The correlation between expression levels of LHβ
and Per2 mRNA (R2 = 0.69, ** p < 0.01: n = 98) and that between expression levels of LHβ
and Cry1 (R2 = 0.48, ** p < 0.01: n = 98) were also significant, but they were relatively
weak compared with the correlation between expression levels of LHβ and Bmal1/Clock
in LβT2 cells.
2.3. Involvement of MAPKs in GnRH-Induced LH and Clock Gene Expression
Involvement of the MAPK pathway, which has been reported to have a key func-
tional role in LβT2 cells [25–27], in the regulation of GnRH-induced LHβ expression was
then examined. As shown in Figure 2A, GnRH (10 nM) stimulation for 15 min readily
activated the phosphorylation of MAPKs, including ERK, p38, and SAPK/JNK signaling,
in LβT2 cells. As shown in Figure 2B, GnRH treatment for 6 h significantly reduced the
mRNA expression levels of LH, Bmal1, and Clock. However, among the treatments with
MAPK inhibitors including U0126, SB203580, and SP600125 (1 or 3 µM), only treatment
with U0126 abolished the GnRH-induced suppression of LH, Bmal1, and Clock mRNA
expression, indicating that, at the early phase, the ERK pathway is functionally linked to
the regulation of LHβ mRNA expression as well as Bmal1/Clock mRNA expression in
gonadotrope cells stimulated by GnRH (Figure 2B). In contrast, as shown in Figure 2C,
GnRH treatment did not affect the mRNA levels of Per2 and Cry1 in LβT2 cells. These
results indicated that the changes in mRNA expression of Bmal1/Clock, rather than the
changes in mRNA expression of Per2/Cry1, were functionally involved in LHβ expression
in LβT2 cells at the early phase of GnRH stimulation.
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Figure 2. Involvement of MAPK in the regulation of LH and Clock gene expression induced by GnRH in gonadotrope 
cells. (A) LβT2 cells (1 × 105 cells/mL) were stimulated with GnRH (10 nM) in serum-free DMEM, and after 15-min stimu-
lation, the cells were lysed and subjected to immunoblot (IB) analysis using antibodies that detect phosphorylation of 
Figure 2. Involvement of MAPK in the regulation of LH and Clock gene expression induced by GnRH in gonadotrope cells.
(A) LβT2 cells (1 × 105 cells/mL) were stimulated with GnRH (10 nM) in serum-free DMEM, and after 15-min stimulation,
the cells were lysed and subjected to immunoblot (IB) analysis using antibodies that detect phosphorylation of MAPKs.
The results are representative of those obtained from at least three independent experiments. The relative integrated
density of the ERK protein band was digitized, with the phosphorylated levels being normalized by the total levels, and
the results were expressed as fold changes. Results are shown as means ± SEM and were analyzed by the unpaired t-test:
* p < 0.05 between the indicated groups. (B) Cells (1 × 105 cells/mL) were treated with the indicated concentrations of
GnRH and MAPK inhibitors, including U0126, SP203580, and SP600125 in serum-free conditions for 6 h. Total RNAs
were extracted, and the mRNA levels of LHβ, Bmal1, and Clock were standardized by RPL19 levels and expressed as fold
changes. Results are shown as means ± SEM and were analyzed by the ANOVA: * p < 0.05 between the indicated groups.
(C) Cells (1 × 105 cells/mL) were treated with GnRH (10 nM) in serum-free conditions for 6 h, and after the extraction of
total RNAs, the mRNA levels of Per2 and Cry1 mRNA were standardized by RPL19 levels and expressed as fold changes.
Results are shown as means ± SEM and were analyzed by the unpaired t-test.
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2.4. Inhibitory Effects of Clock Gene Expression and Its Involvement of BMPs
Next, to investigate the effects of Bmal1 and Clock expression on GnRH-induced LHβ
expression at the late phase of GnRH stimulation, the siRNA-targeting method was used
in LβT2 cells. As shown in Figure 3A, Bmal1 and Clock expression levels were reduced
by 63% and 66%, respectively, by transfecting each siRNA. In the knock-down conditions
of Bmal1 and Clock expression, LHβ mRNA levels at the late phase 24 h after GnRH
stimulation were significantly reduced by 71% and 81%, respectively, compared to the
corresponding conditions treated with GnRH and control siRNA. Furthermore, to clarify
the functional interaction between Clock genes and pituitary BMPs, LβT2 cells were treated
with BMP-6 and -7 (30 ng/mL) for 24 h in the presence of GnRH (10 nM) as shown in
Figure 3B. It was revealed that BMP-6, as well as BMP-7, significantly suppressed LHβ and
Bmal1 mRNA expression in the late phase after GnRH treatment. On the other hand, the
effects of BMP-6 and BMP-7 on the mRNA expression levels of GnRH-induced Clock were
relatively modest compared to the effect of Bmal1.




Figure 3. Effects of Clock gene suppression and BMPs on LH and Clock genes expression induced by GnRH in gonado-
trope cells. (A) LβT2 cells (1 × 105 cells/mL) were transiently transfected with Bmal1- or Clock-specific RNA or control 
siRNA and then incubated with or without GnRH (10 nM) for 24 h. Total RNAs were extracted, and the mRNA levels of 
Figure 3. Cont.
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Figure 3. Effects of Clock gene suppression and BMPs on LH and Clock genes expression induce i onadotrope
cells. (A) LβT2 cells (1 × 105 cells/mL) were transiently transfected with Bmal1- or Clock-specific RNA or control siRNA
and then incubated with or without GnRH (10 nM) for 24 h. Total RNAs were extracted, and the mRNA levels of Bmal1,
Clock and LHβ were standardized by RPL19 levels and expressed as fold changes. (B) Cells (1 × 105 cells/mL) were treated
with BMP-6 and -7 (30 ng/mL) in serum-free DMEM in the presence or absence of GnRH (10 nM). After 24 h culture, total
RNAs were extracted, and the mRNA levels of LHβ, Bmal1, and Clock mRNA were standardized by RPL19 levels and
expressed as fold changes. Results are shown as means ± SEM. The results were analyzed by the unpaired t-test or ANOVA.
The values with different superscript letters are significantly different at p < 0.05, and * p < 0.05 between the indicated groups
and vs. control groups. (C) Biphasic effects of Clock genes and BMPs on GnRH-induced LH expression by gonadotrope
cells. GnRH stimulation exhibits inhibitory effects on Bmal1/Clock expression at the early phase via the ERK pathway,
leading to suppression of LH expression. At the late phase of GnRH stimulation, GnRH increases LH mRNA expression via
upregulation of Bmal1/Clock expression, with BMP-6 and -7 suppressing the expression of Bmal1 induced by GnRH. Thus,
phase-dependent roles of MAPK and BMPs in Clock gene-dependent LH expression induced by GnRH were shown in
gonadotrope cells.
3. Discussion
In the present study, biphasic effects of GnRH on the expression of Clock genes
and LHβ were revealed by using gonadotrope cells (Figure 3C). GnRH stimulation had
inhibitory effects on Bmal1/Clock expression at the early phase via the ERK/MAPK
pathway, leading to suppression of LH expression. On the other hand, at the late phase of
GnRH stimulation, GnRH increased LH mRNA levels via upregulation of Bmal1/Clock
expression, and BMP-6 and -7 suppressed the expression of Bmal1 induced by GnRH.
Based on the findings, functional roles of MAPK and BMPs in Clock gene-dependent LH
expression induced by GnRH were uncovered in gonadotrope cells.
It was of note that there were phase-dependent effects of GnRH on the expression of
Clock genes and LH by gonadotrope cells. GnRH stimulation exhibited inhibitory effects
on Bmal1/Clock and LH mRNA expression at the early phase, while at the late phase,
GnRH increased LH mRNA expression via upregulation of Bmal1/Clock expression. In
this regard, a lack of proestrous LH surge has been reported in Clock-mutant mice [28] and
also in Bmal1-null female mice [29], suggesting that Clock and Bmal1 play a key regulatory
role in gonadotropin release from the pituitary. In view of the reproductive functions
in the pituitary, Miller et al. evaluated pituitary function in vivo by measuring serum
LH following treatment with GnRH in wild-type and Clock-mutant female mice [28]. In
their study, the results for pituitary LH release after GnRH stimulation were the same in
wild-type and mutant female mice, indicating that pituitary responsiveness to GnRH is
normal regardless of the disruption of Clock action [28]. The estrous cycle defects seen in
the Clock mutants were thus likely to have been caused by the disrupted coordination of
hypothalamic GnRH release. However, the in vitro results in the present study revealed
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that disruption of Clock/Bmal gene expression can also directly affect the LH expression
by gonadotrope cells.
In addition to the roles of Bmal/Clock, the influence of Per1 and other Clock genes
on gonadotropin expression suggests the presence of complicated feedback loops that
are critical for the maintenance of normal reproductive functions. Functional roles of the
Per1 gene were shown in experiments using immortalized gonadotrope cell lines [30], in
which Per1 expression was acutely upregulated by GnRH treatment [31]. In the present
study, it was found that GnRH stimulation exhibited inhibitory effects on Bmal1/Clock
expression at the early phase via ERK activation, leading to suppression of LH expression.
The signaling pathways of GnRH-induced LHβ transcription are also known to involve
PKC signaling in gonadotropes, resulting in activation of the ERK pathway and immediate
early genes such as early growth response protein 1 (EGR-1) [32]. EGR-1 is a critical
transcription factor for GnRH-induced LH synthesis, and the presence of an EGR-1 binding
site was detected in the proximal promoter region of the Per1 gene [33]. Thus, it is
of interest that the Clock genes are functionally linked to rapid intracellular pathways
including MAPKs and EGR-1 in transactivating LH as well as Clock genes in gonadotrope
cells at the early phase of GnRH stimulation.
The pituitary BMP system has been shown to be involved in cellular differentiation
and functional transition of gonadotropin productivity in pituitary gonadotropes [34].
Expression of BMP type-I and type-II receptors has also been reported in gonadotrope
cells in various species [11,22]. Regarding the regulation of gonadotropin production by
BMPs, it has been shown that BMP-6 and -7 can stimulate FSH synthesis and secretion by
gonadotrope LβT2 cells [35]. BMP-15 has also been shown to stimulate FSH, but not LH,
biosynthesis, and secretion by rat primary pituitary cells [22]. The present study revealed
the involvement of BMP-6 and -7 in the regulation of LH expression at the late phase of
GnRH stimulation by gonadotrope cells, in which both BMPs suppressed the expression
of Bmal1 induced by GnRH. Differential expression of follistatin, a BMP-binding protein,
depending on FSH productivity, was also shown in human pituitary adenomas [23]. A
functional role of BMP-6 in GnRH-induced LH secretion by modulating the responsiveness
to somatostatin analogs was also found in gonadotrope cells [27]. BMPs are also known
to operate through Smad-independent pathways such as MAPK signaling molecules.
In gonadotrope cells, signal interaction between GnRH-induced MAPK signaling and
BMPs/activins for gonadotropin secretion has been shown [36], and the signal interaction
might be, at least in part, involved in GnRH-induced suppression of LH expression at the
early phase. However, the results of the present study revealed that pituitary BMPs are
likely to be indirect modulators for gonadotropin regulation in the chronic phase of GnRH
treatment by gonadotrope cells.
Collectively, the results indicated that LH expression by gonadotrope cells exhibits
Bmal1/Clock-dependent changes in the presence of GnRH in a phase-dependent manner
(Figure 3C). The results also suggested that the pituitary BMP system acts as a functional
modulator for Clock gene expression in an autocrine/paracrine manner, leading to fine-
tuning of the phase-dependent sensitivity to GnRH for LH expression by gonadotrope cells.
Control of Clock gene expression by regulating the ERK pathway at the early phase as well
as by regulating the BMP-Smad signal at the chronic phase could be a future strategy for
modulation of the LH surge exerted by pituitary gonadotropes.
4. Materials and Methods
4.1. Reagents and Cell Culture
Dulbecco’s modified Eagle’s medium (DMEM) and GnRH human acetate salt were
purchased from Sigma-Aldrich Co. Ltd. (St. Louis, MO, USA), and recombinant proteins
of human BMP-6 and BMP-7 were purchased from R&D Systems Inc. (Minneapolis, MN,
USA). The ERK inhibitor U0126 and P38 inhibitor SB203580 were from Promega Corp.
(Madison, WI, USA), and the SAPK/JNK inhibitor SP600125 was from Biomol Lab. Inc.
(Plymouth Meeting, PA, USA). LβT2 cells, originating from a mouse gonadotrope cell
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line, were cultured in DMEM containing 10% fetal calf serum (FCS) supplemented with
penicillin-streptomycin with 5% CO2 at 37 ◦C.
4.2. Quantitative Real-Time PCR Analysis
LβT2 cells (1 × 105 cells/1 mL per well) were treated with GnRH (10 nM) in com-
bination with MAPK inhibitors, including U0126, SP203580 and SP600125 (1 or 3 µM),
and BMP-6 and -7 (30 ng/mL) in serum-free DMEM in 12-well plates for the indicated
periods. Total RNAs of LβT2 cells were then extracted by the method using TRI Reagent®
(Cosmo Bio Co., Ltd., Tokyo, Japan), and RNA concentrations were calculated using a
NanoDropTM One spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).
Primer pairs were chosen from different exons to exclude PCR products derived from
chromosomal DNA. Primers for Clock and ribosomal protein L19 (RPL19), a housekeeping
gene, were prepared as reported previously [37,38]. Other primer sequences were selected
as follows: 129–148 and 355–374 for LHβ (from GenBank accession #NM_008497), 923–943
and 1056–1076 for Bmal1 (AB015203), 1931–1950, and 2147–2166 for Per2 (NM_011066), and
1638–1657 and 1812–1831 for Cry1 (NM_007771). ReverTra Ace® (Toyobo Co., LTD., Osaka,
Japan) was used for reverse transcription, and then real-time PCR analysis was performed
using the LightCycler® Nano real-time PCR system (Roche Diagnostic Co., Tokyo, Japan).
After optimization of each annealing condition and amplification efficiency [38], mRNA
levels of target genes were evaluated by the method using the ∆ threshold cycle (Ct). The
∆Ct value was determined by subtracting the Ct values of RPL19 from those of the target
genes. Each mRNA level of the target gene was normalized by the level of RPL19 and was
calculated as 2−(∆Ct). The data were shown as ratios of target genes to RPL19 mRNA.
4.3. Western Immunoblotting Analysis
LβT2 cells (1 × 105 cells/1 mL per well) were treated by 15-min stimulation with
GnRH (10 nM) in serum-free DMEM in 12-well plates. After the stimulation, the cells
were solubilized in 100 µL RIPA lysis buffer (Upstate Biotechnology, Lake Placid, NY,
USA) containing 1 mM Na3VO4, 1 mM NaF, 2% SDS, and 4% β-mercaptoethanol. The
protein concentration of the samples was measured using Bio-Rad Protein Assay (Bio-Rad
Laboratories, Inc., Hercules, CA, USA). The cell lysates that contained approximately 4 µg
protein/well were subjected to gel-running on SDS-PAGE using 17-well NuPAGE® 4%–12%
Bis-Tris Gels (Thermo Fisher Scientific) and were then transferred to PVDF membranes.
Immunoblotting was performed using primary antibodies including anti-phospho- and
anti-total-ERK1/2, P38, and SAPK/JNK antibodies (Cell Signaling Technology, Inc., Beverly,
MA, USA) at 1:500 dilutions with Can Get Signal® Immunoreaction Enhancer Solution
(Toyobo Co., Ltd.) for 1 h and an anti-IgG secondary antibody (1:5000 dilution) for 1 h.
After membrane washing using phosphate-buffered saline with 1% Tween®20 detergent
(PBST), data visualization was performed using substrate solutions (ImmunoStar LD,
Wako Pure Chemical Industries, Ltd., Osaka, Japan). The integrated signal densities were
scanned by the C-DiGit® Blot Scanner System and digitized by Image Studio for C-Digit
(LI-COR Biosciences, Lincoln, NE, USA). For evaluating protein phosphorylation, ratios of
the digitized intensities of phosphorylated protein/total protein were analyzed.
4.4. Transient Transfection for siRNA Experiments
LβT2 cells (1 × 105 cells/1 mL per well) were cultured in DMEM with 10% FCS in 12-
well plates. Bmal1- or Clock-specific siRNA or control siRNA duplex (10 µM; 30 pmol/well)
was transiently transfected to the cells for 7 h by using the transfection reagents according
to the protocol (https://datasheets.scbt.com/siRNA_protocol.pdf. Accessed 16 Oct 2021)
from the manufacturer (Santa Cruz Biotechnology, Santa Cruz, CA, USA) [37,39,40]. The
cells were subsequently incubated in serum-free medium with or without GnRH (10 nM)
for 24 h. Then the culture medium was removed, and total cellular RNA was isolated by
the method using TRI Reagent® (Cosmo Bio Co., Ltd.). The collected RNA was subjected
to quantitative PCR to evaluate the mRNA levels of Bmal1, Clock, and LHβ.
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4.5. Statistics
Data were obtained from at least three independent experiments with sample triplica-
tion. All of the results are shown as means ± SEM. Statistical analysis was performed by
ANOVA with Tukey–Kramer’s post-hoc test, Fisher’s LSD test, or unpaired t-test (StatView
5.0 software, Abacus Concepts, Inc., Berkeley, CA, USA). * p values < 0.05 and ** p < 0.01
were accepted as statistically significant.
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